Effect of Simvastatin on Arterial Stiffness in Patients with Statin Myalgia.

Advances in Preventive Medicine Pub Date : 2015-01-01 Epub Date: 2015-07-15 DOI:10.1155/2015/351059
Kevin D Ballard, Lindsay Lorson, C Michael White, Paul D Thompson, Beth A Taylor
{"title":"Effect of Simvastatin on Arterial Stiffness in Patients with Statin Myalgia.","authors":"Kevin D Ballard, Lindsay Lorson, C Michael White, Paul D Thompson, Beth A Taylor","doi":"10.1155/2015/351059","DOIUrl":null,"url":null,"abstract":"<p><p>Statins reduce arterial stiffness but are also associated with mild muscle complaints. It is unclear whether individuals with muscle symptoms experience the same vascular benefit or whether statins affect striated and smooth muscle cells differently. We examined the effect of simvastatin treatment on arterial stiffness in patients who did versus those who did not exhibit muscle symptoms. Patients with a history of statin-related muscle complaints (n = 115) completed an 8 wk randomized, double-blind, cross-over trial of daily simvastatin 20 mg and placebo. Serum lipids and pulse wave velocity (PWV) were assessed before and after each treatment. Muscle symptoms with daily simvastatin treatment were reported by 38 patients (33%). Compared to baseline, central PWV decreased (P = 0.01) following simvastatin treatment but not placebo (drug ∗ time interaction: P = 0.047). Changes in central PWV with simvastatin treatment were not influenced by myalgia status or time on simvastatin (P ≥ 0.15). Change in central PWV after simvastatin treatment was inversely correlated with age (r = -0.207, P = 0.030), suggesting that advancing age is associated with enhanced statin-mediated arterial destiffening. In patients with a history of statin-related muscle complaints, the development of myalgia with short-term simvastatin treatment did not attenuate the improvement in arterial stiffness. </p>","PeriodicalId":7388,"journal":{"name":"Advances in Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2015/351059","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Preventive Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2015/351059","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2015/7/15 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Statins reduce arterial stiffness but are also associated with mild muscle complaints. It is unclear whether individuals with muscle symptoms experience the same vascular benefit or whether statins affect striated and smooth muscle cells differently. We examined the effect of simvastatin treatment on arterial stiffness in patients who did versus those who did not exhibit muscle symptoms. Patients with a history of statin-related muscle complaints (n = 115) completed an 8 wk randomized, double-blind, cross-over trial of daily simvastatin 20 mg and placebo. Serum lipids and pulse wave velocity (PWV) were assessed before and after each treatment. Muscle symptoms with daily simvastatin treatment were reported by 38 patients (33%). Compared to baseline, central PWV decreased (P = 0.01) following simvastatin treatment but not placebo (drug ∗ time interaction: P = 0.047). Changes in central PWV with simvastatin treatment were not influenced by myalgia status or time on simvastatin (P ≥ 0.15). Change in central PWV after simvastatin treatment was inversely correlated with age (r = -0.207, P = 0.030), suggesting that advancing age is associated with enhanced statin-mediated arterial destiffening. In patients with a history of statin-related muscle complaints, the development of myalgia with short-term simvastatin treatment did not attenuate the improvement in arterial stiffness.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
辛伐他汀对他汀类肌痛患者动脉僵硬的影响。
他汀类药物可减少动脉僵硬,但也与轻度肌肉不适有关。目前尚不清楚是否有肌肉症状的个体对血管有相同的益处,或者他汀类药物对横纹肌和平滑肌细胞的影响是否不同。我们检查了辛伐他汀治疗对出现肌肉症状的患者和未出现肌肉症状的患者动脉僵硬的影响。有他汀类药物相关肌肉疾病史的患者(n = 115)完成了一项为期8周的随机、双盲、交叉试验,每日服用辛伐他汀20mg和安慰剂。检测各组治疗前后血脂及脉搏波速度(PWV)。38例患者(33%)报告了每日辛伐他汀治疗后的肌肉症状。与基线相比,辛伐他汀治疗后中枢性PWV下降(P = 0.01),而安慰剂治疗后没有下降(药物∗时间相互作用:P = 0.047)。辛伐他汀治疗中枢性PWV的变化不受肌痛状态或辛伐他汀治疗时间的影响(P≥0.15)。辛伐他汀治疗后中枢性PWV的变化与年龄呈负相关(r = -0.207, P = 0.030),表明年龄的增长与他汀介导的动脉硬化增强有关。在有他汀类药物相关肌肉疾病史的患者中,短期辛伐他汀治疗后出现肌痛并没有减弱动脉僵硬度的改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
6
审稿时长
15 weeks
期刊最新文献
Prevalence and Factors Associated with Postoperative Nausea and Vomiting in an Ethiopian Comprehensive Specialized Hospital Financial Losses Arising from Cattle Organ and Carcass Condemnation at Lokoloko Abattoir in Wau, South Sudan. Clinical and Histopathological Factors Associated with the Tumoral Expression of TGF-β1, MED15, CD16, and CD57 in Oral Squamous Cell Carcinoma. Prevalence of Caries among School Children in Saudi Arabia: A Meta-Analysis. Effectiveness of a Community Health Worker-Led Intervention on Knowledge, Perception, and Prostate Cancer Screening among Men in Rural Kenya.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1